用病毒治癌症!武汉滨会生物港股IPO,乐普生物参投

项乾
Nov 05, 2025

本文综合自:格隆汇、融资中国近期,武汉滨会生物科技股份有限公司(下称“滨会生物”)提交了招股说明书,拟港股IPO上市,华泰国际、招银国际、中银国际担任保荐人。滨会生物成立于2010年11月,总部位于武汉东湖新技术开发区。由已获批上市溶瘤病毒T-VEC(Imlygic)的原研团队成员刘滨磊博士创办,是产学研一体化、全闭环开发和生产溶瘤病毒的龙头企业,已建立丰富且多元化的产品管线,布设了强力抗癌的“...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10